Formulation and Evaluation of Fast Disintegrating Tablet of Salbutamol Sulphate
DOI:
https://doi.org/10.3126/jucms.v12i02.69619Keywords:
Fast disintegrating tablet, Direct compression method, Salbutamol sulphateAbstract
INTRODUCTION
When put on the tongue, fast dissolving tablets immediately dissolve, often in a matter of seconds. They do not need any additional water to make them easier to swallow. Salbutamol sulphate fast disintegrating tablets have a higher bioavailability and dissolving rate.
MATERIAL AND METHODS
This experimental study was conducted in the Pharmaceutic laboratory of Department of Pharmacy at Universal College of Medical Sciences, Bhairahawa, Nepal from February 2022 to July 2022. A tablet was created utilizing the direct compression method employing mannitol as a diluent and various quantities of super disintegrants, including sodium starch glycolate, croscarmellose sodium, and PVPK-30 as a binder. Pre-compression and post-compression parameters for the formulation were evaluated.
RESULTS
When examined for hardness, thickness, weight variation, in vitro disintegration time, drug content, and in vitro drug release, tablets were determined to be adequate. Among all formulations, F6 showed that its disintegration time is least and in-vitro dissolution test depicts that F6 formulation shows the maximum drug release (99.99%) within 30 minutes.
CONCLUSION
This study brings the effectiveness in dosing of patients who have problem in swallowing of conventional dosage form. Among formulations, 15 mg of croscarmellose sodium was found to be the best.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Journal of Universal College of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors have to give the following undertakings along with their article:
- I/we declare that this article is original and has not been submitted to another journal for publication.
- I/we declare that I/we surrender all the rights to the editor of the journal and if published will be the property of the journal and we will not publish it anywhere else, in full or part, without the permission of the Chief Editor.
- Institutional ethical and research committee clearance certificate from the institution where work/research was done, is required to be submitted.
- Articles in the Journal are Open Access articles published under the Creative Commons CC BY-NC License (https://creativecommons.org/licenses/by-nc/4.0/)
- This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, and it is not used for commercial purposes.